A new 4-(pyridinyl)-4H-benzo[g]chromene-5,10-dione ruthenium(II) complex inducing senescence in 518A2 melanoma cells

New (arene)ruthenium(II) complexes of 4‑aryl‑4 H ‑naphthopyrans with anticancer and anti-vascular activities

(2018) Florian Schmitt et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?

(2018) Sreekanth Thota et al.   JOURNAL OF MEDICINAL CHEMISTRY

Novel Antitumor Platinum(II) Conjugates Containing the Nonsteroidal Anti-inflammatory Agent Diclofenac: Synthesis and Dual Mechanisms of Antiproliferative Effects

(2017) Francesco Paolo Intini et al.   INORGANIC CHEMISTRY

Morphological and Functional Characteristic of Senescent Cancer Cells

(2016) Ewa Sikora et al.   CURRENT DRUG TARGETS

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016

(2016) Claus Garbe et al.   EUROPEAN JOURNAL OF CANCER

Arene-Ruthenium(II) Complexes with Bioactiveortho-Hydroxydibenzoylmethane Ligands: Synthesis, Structure, and Cytotoxicity

(2016) Riccardo Pettinari et al.   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands

(2016) Bernhard Biersack   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe – a systematic review of the literature

(2016) Fernanda Costa Svedman et al.   Clinical Epidemiology

Senescence from G2 arrest, revisited

(2015) Véronique Gire et al.   CELL CYCLE

Exploiting tumor cell senescence in anticancer therapy

(2014) Minyoung Lee et al.   BMB Reports

β-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells

(2014) E J Park et al.   Cell Death & Disease

Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions

(2013) Rossella Marullo et al.   PLoS One

Structural simplification of bioactive natural products with multicomponent synthesis. 4. 4H-Pyrano-[2,3-b]naphthoquinones with anticancer activity

(2012) Igor V. Magedov et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

From Body Art to Anticancer Activities: Perspectives on Medicinal Properties of Henna

(2012) Rohan Pradhan et al.   CURRENT DRUG TARGETS

The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression

(2010) Jean-Philippe Coppé et al.   Annual Review of Pathology-Mechanisms of Disease

Ruthenium-based chemotherapeutics: are they ready for prime time?

(2010) Emmanuel S. Antonarakis et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

β-Lapachone-induced reactive oxygen species (ROS) generation mediates autophagic cell death in glioma U87 MG cells

(2010) Eun Jung Park et al.   CHEMICO-BIOLOGICAL INTERACTIONS

(Arene)Ru(II) complexes of epidermal growth factor receptor inhibiting tyrphostins with enhanced selectivity and cytotoxicity in cancer cells

(2010) B. Biersack et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Therapy-Induced Senescence in Cancer

(2010) Jonathan A. Ewald et al.   JNCI-Journal of the National Cancer Institute

Inflammatory networks during cellular senescence: causes and consequences

(2010) Adam Freund et al.   TRENDS IN MOLECULAR MEDICINE

KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients

(2008) Christian G. Hartinger et al.   CHEMISTRY & BIODIVERSITY

C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells

(2008) D Zhuang et al.   ONCOGENE